Cargando…

Data quality of drug-resistant tuberculosis and antiretroviral therapy electronic registers in South Africa

BACKGROUND: To assess the quality and completeness of treatment and outcome data in the electronic tuberculosis (TB) and antiretroviral treatment (ART) registers in drug-resistant (DR-) TB patients at three treatment facilities in South Africa. METHODS: We did a retrospective cohort study using rout...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jamieson, Lise, Evans, Denise, Berhanu, Rebecca, Ismail, Nazir, Aucock, Samantha, Wallengren, Kristina, Long, Lawrence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896407/ https://www.ncbi.nlm.nih.gov/pubmed/31805982 http://dx.doi.org/10.1186/s12889-019-7965-9

Ejemplares similares

Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa
por: Berry, Kaitlyn M., et al.
Publicado: (2019)

Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa
por: van Rensburg, Craig, et al.
Publicado: (2019)

Can Short-Term Use of Electronic Patient Adherence Monitoring Devices Improve Adherence in Patients Failing Second-Line Antiretroviral Therapy? Evidence from a Pilot Study in Johannesburg, South Africa
por: Evans, Denise, et al.
Publicado: (2016)

Treatment and pregnancy outcomes of pregnant women exposed to second-line anti-tuberculosis drugs in South Africa
por: Mokhele, Idah, et al.
Publicado: (2021)

Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa
por: Evans, Denise, et al.
Publicado: (2017)

Insights into Adherence among a Cohort of Adolescents Aged 12–20 Years in South Africa: Reported Barriers to Antiretroviral Treatment
por: Maskew, Mhairi, et al.
Publicado: (2016)

Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa
por: Evans, Denise, et al.
Publicado: (2018)

Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study
por: Berhanu, Rebecca, et al.
Publicado: (2016)

The impact of adverse events on health-related quality of life among patients receiving treatment for drug-resistant tuberculosis in Johannesburg, South Africa
por: Sineke, Tembeka, et al.
Publicado: (2019)

Evaluating the electronic tuberculosis register surveillance system in Eden District, Western Cape, South Africa, 2015
por: Mlotshwa, Mandla, et al.
Publicado: (2017)

Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa
por: Evans, Denise, et al.
Publicado: (2018)

The Prevalence and Drug Sensitivity of Tuberculosis among Patients Dying in Hospital in KwaZulu-Natal, South Africa: A Postmortem Study
por: Cohen, Ted, et al.
Publicado: (2010)

Drug-Resistant Tuberculosis, KwaZulu-Natal, South Africa, 2001–2007
por: Wallengren, Kristina, et al.
Publicado: (2011)

High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa
por: Hirasen, Kamban, et al.
Publicado: (2018)

Treatment outcomes of over 1000 patients on second‐line, protease inhibitor‐based antiretroviral therapy from four public‐sector HIV treatment facilities across Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2016)

Developing a predictive risk model for first-line antiretroviral therapy failure in South Africa
por: Rohr, Julia K, et al.
Publicado: (2016)

Low prevalence of depressive symptoms among stable patients on antiretroviral therapy in Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2018)

Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study
por: Schnippel, Kathryn, et al.
Publicado: (2016)

Distribution and Clonality of drug-resistant tuberculosis in South Africa
por: Said, Halima, et al.
Publicado: (2021)

Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa
por: Onoya, Dorina, et al.
Publicado: (2017)

Using a Self-Administered Electronic Adherence Questionnaire to Identify Poor Adherence Amongst Adolescents and Young Adults on First-Line Antiretroviral Therapy in Johannesburg, South Africa
por: Hirasen, Kamban, et al.
Publicado: (2020)

Initial loss to follow up of tuberculosis patients in South Africa: perspectives of program managers
por: Mwansa-Kambafwile, Judith R. M., et al.
Publicado: (2020)

Mortality during tuberculosis treatment in South Africa using an 8-year analysis of the national tuberculosis treatment register
por: Osman, Muhammad, et al.
Publicado: (2021)

Determining the risk-factors for molecular clustering of drug-resistant tuberculosis in South Africa
por: Said, Halima, et al.
Publicado: (2023)

Pulmonary tuberculosis vs. Tindzhaka and Mafularha: A mixed methods inquiry of traditional healers’ perceptions of tuberculosis in rural South Africa
por: Audet, Carolyn M., et al.
Publicado: (2023)

Treatment outcomes of HIV-positive patients on first-line antiretroviral therapy in private versus public HIV clinics in Johannesburg, South Africa
por: Moyo, Faith, et al.
Publicado: (2016)

Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care
por: Maskew, Mhairi, et al.
Publicado: (2018)

Predictive and prognostic properties of TB-LAM among HIV-positive patients initiating ART in Johannesburg, South Africa
por: d'Elia, Alexander, et al.
Publicado: (2015)

Prevalence, incidence, predictors, treatment, and control of hypertension among HIV-positive adults on antiretroviral treatment in public sector treatment programs in South Africa
por: Brennan, Alana T., et al.
Publicado: (2018)

Multitype violence exposures and adolescent antiretroviral nonadherence in South Africa
por: Cluver, Lucie, et al.
Publicado: (2018)

Transition to an in-facility electronic Tuberculosis register: Lessons from a South African pilot project
por: Myburgh, Hanlie, et al.
Publicado: (2020)

Stock-outs of antiretroviral and tuberculosis medicines in South Africa: A national cross-sectional survey
por: Hwang, Bella, et al.
Publicado: (2019)

Is Antiretroviral Therapy Cost-Effective in South Africa?
por: Braithwaite, R. Scott, et al.
Publicado: (2006)

The Survival Benefits of Antiretroviral Therapy in South Africa
por: April, Michael D., et al.
Publicado: (2014)

Feasibility of using postal and web-based surveys to estimate the prevalence of tuberculosis among health care workers in South Africa
por: Manana, Pinky N., et al.
Publicado: (2018)

Drug-Resistant Tuberculosis among HIV-Infected Patients Starting Antiretroviral Therapy in Durban, South Africa
por: Hom, Jeffrey K., et al.
Publicado: (2012)

Pregnancy and Virologic Response to Antiretroviral Therapy in South Africa
por: Westreich, Daniel, et al.
Publicado: (2011)

Financing equitable access to antiretroviral treatment in South Africa
por: Cleary, Susan, et al.
Publicado: (2010)

Treatment Outcomes and Costs of Providing Antiretroviral Therapy at a Primary Health Clinic versus a Hospital-Based HIV Clinic in South Africa
por: Long, Lawrence C., et al.
Publicado: (2016)

The relation between efavirenz versus nevirapine and virologic failure in Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0i7h6h17jrijljmc0tb6at9d5j